Clinical Trial Update: Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing rosiglitazone alone vs rosiglitazone with metformin vs rosiglitazone with Avandia for nonalcoholic steatohepatitis and related fatty liv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Avandia (rosiglitazone)
• Rosiglitazone (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease | Phase 2 | Status: UNKNOWN